A phase II, double blind randomised controlled crossover trial of dronabinol for the treatment of cervical dystonia

被引：0
|
作者：
Zadikoff, C.
Wadia, P.
Asante, A.
Fox, S. H.
机构：
来源：
MOVEMENT DISORDERS | 2008年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
482
引用
收藏
页码：S161 / S161
页数：1
相关论文
共 50 条
  • [1] Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial
    Svendsen, KB
    Jensen, TS
    Bach, FW
    BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7460): : 253 - 257
  • [2] Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia
    Ranoux, D
    Gury, C
    Fondarai, J
    Mas, JL
    Zuber, M
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 72 (04): : 459 - 462
  • [3] Bumetanide in hypokalaemic periodic paralysis: a randomised, double-blind, placebo controlled phase II clinical trial with a crossover design
    Scalco, R.
    Skorupinska, I.
    Blochet, C.
    Habib, M.
    Matthews, E.
    Morrow, J.
    Hanna, M.
    Fialho, D.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S197 - S197
  • [4] Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial
    Conde, Marcus B.
    Efron, Anne
    Laredo, Carla
    Muzy De Souza, Gilvan R.
    Graca, Nadja P.
    Cezar, Michelle C.
    Ram, Malathi
    Chaudhary, Mohammad A.
    Bishai, William R.
    Kritski, Afranio L.
    Chaisson, Richard E.
    LANCET, 2009, 373 (9670): : 1183 - 1189
  • [5] A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia
    Hainque, Elodie
    Vidailhet, Marie
    Cozic, Nathalie
    Charbonnier-Beaupel, Fanny
    Thobois, Stephane
    Tranchant, Christine
    Brochard, Vanessa
    Glibert, Gerald
    Drapier, Sophie
    Mutez, Eugenie
    De Maindreville, Anne Doe
    Lebouvier, Thibaud
    Hubsch, Cecile
    Degos, Bertrand
    Bonnet, Cecilia
    Grabli, David
    Legrand, Andre-Pierre
    Meneret, Aurelie
    Azulay, Jean-Philippe
    Bissery, Anne
    Zahr, Noel
    Clot, Fabienne
    Mallet, Alain
    Dupont, Sophie
    Apartis, Emmanuelle
    Corvol, Jean-Christophe
    Roze, Emmanuel
    NEUROLOGY, 2016, 86 (18) : 1729 - 1735
  • [6] A randomised, double blind, placebo controlled, crossover trial of incobotulinum toxin A treatment for upper limb tremor
    Nagaratnam, S.
    Wilson, D.
    Briceno, H. Morales
    Fung, V.
    MOVEMENT DISORDERS, 2023, 38 : S435 - S435
  • [7] Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial
    Levin, Frances R.
    Mariani, John J.
    Brooks, Daniel J.
    Pavlicova, Martina
    Cheng, Wendy
    Nunes, Edward V.
    DRUG AND ALCOHOL DEPENDENCE, 2011, 116 (1-3) : 142 - 150
  • [8] A randomised double blind controlled crossover trial of taurine supplementation in home parenteral nutrition
    Culkin, A.
    Madden, A. M.
    Forbes, A.
    Gabe, S. M.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2010, 69 (OCE2) : E167 - E167
  • [9] Amantadine for treatment of fatigue in Guillain-Barre syndrome:: a randomised, double blind, placebo controlled, crossover trial
    Garssen, MPJ
    Schmitz, PIM
    Merkies, ISJ
    Jacobs, BC
    van der Meché, FGA
    van Doorn, PA
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (01): : 61 - 65
  • [10] Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial
    Frei, H
    Everts, R
    von Ammon, K
    Kaufmann, F
    Walther, D
    Hsu-Schmitz, SF
    Collenberg, M
    Fuhrer, K
    Hassink, R
    Steinlin, M
    Thurneysen, A
    EUROPEAN JOURNAL OF PEDIATRICS, 2005, 164 (12) : 758 - 767
12345